SenesTech, Inc. (NASDAQ:SNES) Sees Large Decline in Short Interest

SenesTech, Inc. (NASDAQ:SNES) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 34,600 shares, a drop of 64.1% from the December 15th total of 96,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Citadel Advisors LLC raised its holdings in SenesTech by 53.2% in the third quarter. Citadel Advisors LLC now owns 20,748 shares of the company’s stock valued at $32,000 after buying an additional 7,205 shares during the period. State Street Corp purchased a new position in SenesTech in the second quarter valued at approximately $40,000. Bank of New York Mellon Corp raised its holdings in SenesTech by 126.4% in the second quarter. Bank of New York Mellon Corp now owns 76,633 shares of the company’s stock valued at $123,000 after buying an additional 42,780 shares during the period. Geode Capital Management LLC purchased a new position in SenesTech in the second quarter valued at approximately $165,000. Finally, Renaissance Technologies LLC purchased a new position in SenesTech in the second quarter valued at approximately $321,000. Hedge funds and other institutional investors own 4.07% of the company’s stock.

SenesTech stock opened at $0.99 on Friday. The firm’s 50-day moving average is $1.17 and its two-hundred day moving average is $1.44. SenesTech has a 12-month low of $0.93 and a 12-month high of $3.14. The stock has a market capitalization of $12.08 million, a P/E ratio of -1.15 and a beta of 1.51.

SenesTech (NASDAQ:SNES) last released its earnings results on Wednesday, November 10th. The company reported ($0.18) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.18). SenesTech had a negative net margin of 1,490.15% and a negative return on equity of 67.90%. The business had revenue of $0.18 million for the quarter, compared to analysts’ expectations of $0.22 million. During the same period last year, the company earned ($0.56) earnings per share. On average, equities research analysts predict that SenesTech will post -0.71 earnings per share for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sector such as animal, structural, and food markets.

Further Reading: Dollar Cost Averaging

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.